Establishment Labs Holdings Inc

Establishment Labs Holdings Inc (ESTA) Stock Analysis

$61.360

+3.688 (+6.01%)At close

Loading chart…
High
62.765
Open
58.800
VWAP
60.87
Volume
484.39K
Mkt Cap
1.21B
Low
58.495
Amount
29.49M
EV/EBITDA, TTM
-178.00

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

AI analysis of Establishment Labs Holdings Inc (ESTA)

Hold

Establishment Labs Holdings Inc is currently a hold. The stock's current price is $61.67, which is significantly below the analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at 33.78, suggesting it is oversold, and the company has been unprofitable with a forward P/E of 204.08, indicating high valuation risk. The main risk is the insider selling, which has increased by 141.15% over the last month, signaling potential lack of confidence from insiders.

Analyst Ratings (3)

+35.07% upside
Buy
3 Buy
0 Hold
0 Sell
Current: 61.36
Low
75.00
Average
82.88
High
90.00

Citi

2026-08-13

Price Target

$92

Buy

Canaccord

2026-08-07

Price Target

$105

Buy

Mizuho

2026-07-15

Price Target

$105

Outperform

Citi

2026-07-08

Price Target

$92

Neutral

BTIG

2026-05-07

Price Target

$90

Buy

Valuation Metrics

The current forward P/E ratio for Establishment Labs Holdings Inc (ESTA) is 204.08, compared to its 5-year average forward P/E of -20.91.

Forward P/E

Strongly Overvalued
5Y Average P/E
-20.91
Current P/E
204.08
Overvalued
20.31
Undervalued
-62.12

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-84.16
Current EV/EBITDA
-178.00
Overvalued
42.04
Undervalued
-210.35

Forward P/S

Undervalued
5Y Average P/S
7.02
Current P/S
5.14
Overvalued
8.84
Undervalued
5.20

Alphio AI Price Scenarios for ESTA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ESTA

$56.20

Scenario price

B

Base

Base · 50%ESTA

$47.64

Scenario price

B

Bear

Bear · 25%ESTA

$46.67

Scenario price

Whales holding ESTA

R

Rice Hall James & Associates, LLC

+ HoldingESTA

+0.56%

3M Return

S

Summit Partners Public Asset Management, LLC

+ HoldingESTA

-1.75%

3M Return

Q

Qatar Holding LLC

+ HoldingESTA

-5.37%

3M Return

B

Boothbay Fund Management, LLC

+ HoldingESTA

-7.72%

3M Return

R

RTW Investments, LP

+ HoldingESTA

-8.29%

3M Return

A

ADAR1 Capital Management, LLC

+ HoldingESTA

-13.31%

3M Return

Events Timeline

2026-09-21 (ET)

08:31:00

Establishment Labs Presents New Data on Breast Tissue Preservation

2026-06-29 (ET)

08:30:00

Establishment Labs Appoints Taylor Harris to Board of Directors

2026-05-06 (ET)

08:10:00

Company Expects Minimally Invasive Business to Exceed $35M in 2026

08:10:00

Company Reports Q1 Revenue of $59.9M, Exceeding Expectations

2026-04-30 (ET)

09:00:00

Establishment Labs Secures $300M Loan Facility

News

ESTA FAQ — answered by Alphio AI

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Establishment Labs Holdings Inc is currently a hold. The stock's current price is $61.67, which is significantly below the analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at 33.78, suggesting it is oversold, and the company has been unprofitable with a forward P/E of 204.08, indicating high valuation risk. The main risk is the insider selling, which has increased by 141.15% over the last month, signaling potential lack of confidence from insiders.

3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading